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Objective: Abdominal aortic aneurysm (AAA) is characterized by inﬂammation, loss of smooth muscle
cells (SMCs), and degradation of the extracellular matrix in the vessel wall. Innate immune receptors
such as Toll-like receptors (TLRs) were recently shown to regulate immunological processes leading to
the formation and progression of atherosclerotic plaques as well as to other cardiovascular pathologies.
Our aim was to investigate whether blockage of TLR signaling, under the control of TIR domain-
containing adaptor protein including IFN-b (TRIF), could inhibit the inﬂammatory response and AAA
development in mice.
Results: In human AAA, an increased TLR3 and TLR4 expression in association with macrophages and T
lymphocytes was demonstrated with immunohistochemical analysis. Angiotensin (Ang) II-induced
aneurysm formation was signiﬁcantly reduced by 30% in ApoE/Trif/ mice compared to ApoE/
mice. Morphologically, AngII-infused ApoE/Trif/ mice had a more intact cellular and extracellular
matrix while ApoE/ mice infused with AngII displayed an increased medial thickness associated with
aortic dissection, thrombus formation, and a more disorganized vessel wall. Gene expression analysis of
the abdominal aorta revealed a profound decrease of the inﬂammatory genes CD68 (P < 0.05), CD11b
(P < 0.05), and TNF-a (P < 0.05) and the protease gene MMP-12 (P < 0.01) in ApoE/Trif/ mice
compared to ApoE/ mice infused with AngII.
Conclusion: Our results suggest that signaling through TRIF is important for the inﬂammatory response
of AngII-induced AAA and that blockage of the TRIF pathway reduces vascular inﬂammation and protects
against AAA formation.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Abdominal aortic aneurysm (AAA) is a common cardiovascular
disease. AAA is associated with atherosclerosis but there are clear
molecular differences between both diseases. Important histolog-
ical features of AAA involve inﬁltration of cells such asmacrophages
and T lymphocytes e representing both innate and adaptive im-
mune responses, respectively e into the aortic wall. These cells, Department of Medical and
g University, SE-58185 Link-
c).
Ireland Ltd. This is an open accessfavor AAA formation through production of various proin-
ﬂammatory cytokines and matrix-degrading proteases resulting in
increased smooth muscle cell (SMC) apoptosis, neovascularization,
and degradation of the extracellular matrix [1e3].
Innate immune receptors such as Toll-like receptors (TLRs) were
recently shown to regulate immunological processes leading to the
formation and progression of atherosclerotic plaques as well as to
other cardiovascular pathologies such as AAA [4e8]. TLRs are
expressed on a number of cell types, including macrophages, mast
cells, B lymphocytes, and dendritic cells, but are also found on
endothelial cells and SMCs, and all of these cell types are present in
AAA and contribute to the inﬂammatory response [6,9]. TLRs play
an essential role in the activation of the innate immune responsearticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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rides, ﬂagellin, double-stranded RNA, and lipopeptides thereby
providing the ﬁrst line of defense against pathogens. In addition,
TLRs also bind host-derived endogenous ligands released upon
tissue damage and tissue remodeling [10], including ﬁbronectin,
hyaluronan fragments, heat shock protein, and heparin sulfate
[11e13]. TLR signaling is controlled by cytoplasmic adaptor pro-
teins, includingmyeloid differentiation factor-88 (MyD88), which is
the universal adaptor for all TLRs (except for TLR3), and TIR
domain-containing adaptor protein including IFN-b (TRIF), which is
the adaptor for TLR3 and TLR4. Triggering of theMyD88-dependent
signaling cascade activates nuclear factor (NF)-kB, and triggering of
the TRIF-dependent pathway results in activation of both NF-kB
and interferon regulating factor (IRF)-3. Both the MyD88- and TRIF-
dependent pathways result in induction of proinﬂammatory me-
diators such as tumor necrosis factor (TNF)-a, interleukin (IL)-1, IL-
6, and interferon (IFN) g [6,10e12,14].
Because aneurysms are characterized by both inﬂammation and
tissue remodeling, the majority of the proposed endogenous TLR
ligands could be present at various stages during disease progres-
sion. Recently, Owens and coworkers showed profound reduction
of angiotensin (Ang) II-induced AAA and atherosclerosis in mice
that were deﬁcient in MyD88 or TLR4 [8]. Due to the ability of TRIF
to regulate inﬂammatory-mediated activation of TNF-a and in-
terleukins among other, inhibition of the TRIF signaling pathway
would potentially inhibit these transcription factors and the sub-
sequent production of a large cohort of inﬂammatory mediators. In
the present studywe sought to investigate the role of TRIF signaling
in AngII-induced AAA formation.
2. Materials and methods
2.1. Human subjects
Patients undergoing elective surgery for infrarenal AAA (n ¼ 12)
after preoperative computed tomography showed an eccentric
intraluminal thrombus were included in the study. Patients were
included after informed, written and, signed consent from the
Karolinska University Hospital, Stockholm, Sweden.
Control aortas were collected from organ donors without clin-
ical or macroscopic signs of aortic atherosclerosis or aneurysm.
Control ascending aorta samples for RNA studies and infrarenal
control aorta samples for histology were collected from medico-
legal autopsies performed in the Department of Forensic Medicine,
University of Helsinki. The sections were immediately snap frozen
in liquid nitrogen for RNA isolation or ﬁxed in 4% formaldehyde for
histology. The use of organ donor and autopsy tissues was approved
by The National Authority for Medicolegal Affairs of Finland.
2.2. AngII-induced aneurysm model in mice
Trif/micewere generated in the Akira laboratory (Department
of Host Defense, Osaka University, Japan) and bred into the ApoE/
background (Center for Molecular Medicine, Karolinska Institute,
Stockholm, Sweden). ApoE/micewere obtained from Taconic and
served as control mice. To induce AAA,mini-osmotic pumps (Model
1004, Alzet, CA, USA) were implanted subcutaneously into the right
ﬂank of ApoE/Trif/ (n¼ 11) and ApoE/ (n¼ 12) mice to release
AngII (1000 ng kg1 min1, cat.no.9525, Sigma Aldrich, St. Louis,
USA) over the course of 28 days. A group of ApoE/ mice were
infused with saline as controls (n ¼ 6). One dose of analgesics,
Buprenorphine (Temgesic, 10 mg/mL), was given subcutaneously
before surgery. Operated animals weremonitored daily for any sign
of pain or disability. Mice were fed a normal chow diet, and water
was provided ad libitum throughout the whole study. After 28 days,the mice were sacriﬁced, whole blood was drawn by jugular vein
puncture, and the aortas were removed and ﬁxated in 4% zinc
formaldehyde for histology analysis or in RNAlater (Ambion, Austin,
TX, USA) for gene expression analysis. The aortic diameter was
measured as the adventitial diameter, and the deﬁnition of an
aneurysmwas set as a 1.5-fold enlargement of the vessel wall. Total
serum cholesterol was measured using Inﬁnity Total Cholesterol
(Fisher Scientiﬁc). The investigation conforms to directive 2010/63/
EU of the European Parliament.
2.3. Real-time reverse-transcription polymerase chain reaction (RT-
PCR) analysis
Suprarenal aortas were homogenized with Tissue Lyser using
safe-lock tubes with metal beads and trizol-chloroform. Total RNA
from the aorta was isolated with the RNeasy Mini kit (Qiagen,
Hilden, Germany) and reversely transcribed with random primers
and Superscript III as described by the manufacturer (Invitrogen,
Carlsbad, CA, USA). cDNA (1.0 ng) was ampliﬁed by RT-PCR re-
actions with TaqMan Universal PCR Mastermix (Applied Bio-
systems, Foster City, CA, USA) in 96-well fast plates on a 7500 Fast
Real-time PCR Sequence Detector (Applied Biosystems). Samples
were run in duplicate and semi-quantiﬁed against a standard curve.
All probes were obtained from Applied Biosystems (Supplementary
table I) and results were normalized to values of human RPLP0 or
murine TBP.
2.4. Immunohistology
Parafﬁn-embedded human abdominal aortas and mouse aortas
were sectioned (5 mm) and rehydrated in several changes of ethanol
and Tissue-Clear® (Sakura Finetek, Leiden, The Netherlands). After
antigen retrieval treatment using Diva decloaker 20 (Biocare
Medical, Concord, CA, USA), endogenous peroxidase activity was
quenched by treatment with 3% hydrogen peroxide for 5 min fol-
lowed by incubation in 5% blocking bovine serum albumin solution.
Sections were then incubated with primary antibodies against
human; a-actin (Sigma Aldrich, Stockholm, Sweden, cat. no.
A5228), von Willebrand factor (Dako, cat. no. A0082), CD68 (Leica
Microsystems, cat. no. NCL-CD68-KP1), CD3 (Santa Cruz Biotech-
nology, cat. no. sc-20047), TLR3 (Sigma Aldrich, cat. no. sc-10740),
and TLR4 (Santa Cruz Biotechnology, cat. no. sc-8694) and pri-
mary antibodies against mouse; CD68 (AbD Serotec, cat. no.
MCA1957) and CD3ε (Bioworld Technology, cat. no. BS3476) over-
night at 4 C. Isotype-matched immunoglobulin at the same con-
centration served as the negative control (Santa Cruz
Biotechnologies, cat. no. NB810-56910). Thereafter, the sections
were incubated with a secondary biotinylated goat anti-rabbit IgG,
goat anti-mouse IgG, goat anti-rat IgG or horse anti-goat IgG (Dako)
antibody. Avidin-biotin peroxidase complexes (Dako) were added
followed by visualization with 3,30-diaminobenzidine tetrahydro-
chloride (Dako). All sections were counterstained with Mayer's
hematoxylin (Histolab Products, G€oteborg, Sweden). Semi-
quantiﬁcation of CD68 and CD3 positive cells on representative
areas of mice aortas was performed blinded.
2.5. Elastin staining
Parafﬁn-embedded aortas (5 mm) were stained with Verhoeff's
hematoxylin for 1 h, differentiated in 2% ferric chloride for 2 min,
and counterstained with Van Gieson's stain for 5 min to identify
elastic ﬁbers in the aortic tissue. Quantiﬁcation of elastin was per-
formed blinded. A scoring system from 1 to 4 was used with 1
deﬁned as intact elastin, 2 as low degradation of elastin, 3 as in-
termediate degradation of elastin, and 4 as high degradation of
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2.6. Masson Trichrome staining
Parafﬁn-embedded sections (5 mm) were incubated in Bouin's
solution (Sigma Aldrich) overnight, counterstained with Weigert's
hematoxylin (Histolab), and then stained with the Masson Tri-
chrome kit (Sigma Aldrich) containing Biebrich's Scarlet-acid
fuchsin for 15 min, phosphomolybdic-phosphotungstic acid solu-
tion for 10 min, and aniline blue for 5 min. Sections were ﬁnally
washed in 1% acetic acid for 3 min. Collagen displays a blue staining
and cytoplasm and muscle ﬁbers are stained red.
2.7. Statistical analysis
The statistical analysis was performed with IBM SPSS Statistics
(Version 22). All measurements are represented as median and SD.
P-values< 0.05 are considered statistically signiﬁcant. Two-group
comparisons of the quantitative data were performed using the
non-parametric ManneWhitney Rank Sum test.
3. Results
3.1. Expression of TLR3, TLR4 and TRIF in human AAA
Immunohistochemical analysis of human aortas with AAA (Fig.
1) demonstrated a high expression of TLR3 and TLR4 (Fig. 1B and
C). The expression was to some extent associated in areas of SMCsFig. 1. Immunohistochemical staining of human AAA and control aorta. Overview of aneurys
Histological staining of TLR-3 (B), TLR-4 (C), macrophage marker CD68 (D) and T lymphocyt
aorta. Black arrows indicate positive staining and red arrows indicate blood vessel from theand endothelial cells (data not shown) but more frequently
expressed in the same areas as macrophages and T lymphocytes
(Fig. 1DeE). Non-aneurysmal control aortas only expressed TLR3
and TLR4 weakly in media but not adventitia layer of the aorta
(Fig. 1FeG). The geneeexpression proﬁle showed twice as high
expression of TLR4 (P < 0.001), but there were no differences in
TLR3 or Trif within the aneurysmal wall compared to non-
aneurysmal control aortas (Fig. 2).3.2. TRIF deﬁciency reduces AngII-induced AAA in mice
To determine whether disrupted TRIF signaling could inﬂuence
AAA formation, ApoE/ mice deﬁcient in TRIF were infused with
AngII for 28 days. Histological features of the aneurysmal ApoE/
mice aortas infused with AngII revealed a markedly expanded
aortic mass and disorganized adventitial tissue compared to saline-
infused ApoE/ control aortas when stained with Masson Tri-
chrome (Fig. 3A and B). The presence of a thrombus was also
identiﬁed in the adventitial regions in some of the aneurysmal
aortas (Fig. 3B). However, aortas from ApoE/Trif/ mice infused
with AngII (Fig. 3C) were similar to the saline-infused control aortas
and displayed a more organized vessel wall and did not have any
thrombotic material or aortic masses compared with aortas from
aneurysmal ApoE/ mice.
An aorta was classiﬁed as an AAA when the adventitial aortic
diameter was increased by at least 50% compared to saline-infused
control mouse aortas (0.46 ± 0.05 mm). This corresponds to an
enlargement by > 0.68 mm. The absence of TRIF resulted in a 30%mal vessel with CD3 positive staining (A) including a square indicating magniﬁed area.
e marker CD3 (E) in human AAA and TLR3 (F) and TLR4 (G) in non-aneurysmal control
same area. A indicates adventitia and M indicates media. Scale bar represents 50 mm.
Fig. 2. Gene expression of TLR3 (A), TLR4 (B) and the adaptor protein Trif (C) from human non-aneurysmal control aortas and AAA samples as determined by real-time PCR.
***P < 0.001. “B” Outlier greater than 1.5 times the interquartile range. “C” Outlier greater than 3 times the interquartile range.
Fig. 3. Histological staining with Masson Trichrome of saline-infused ApoE/ control
mouse aorta (A), AngII-infused ApoE/ mouse aorta whereas a blood clot is present
(arrow) (B) and AngII-infused ApoE/Trif/ mouse aorta (C). Scale bar ¼ 50 mm.
Fig. 4. Adventitial aorta diameter (A) and the percentage of mice with aneurysm (B) in
saline-infused ApoE/ mice and AngII-infused ApoE/ and ApoE/Trif/ mice.
*P < 0.05, **P < 0.01. Grey bar represent no aneurysm and black bar represent
aneurysm.
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AngII-infused ApoE/ mice (0.78 ± 0.26 mm) (P < 0.05; Fig. 4A).
After AngII infusion, 55% of the ApoE/ mice developed an aneu-
rysm but only 9% of the ApoE/Trif/mice developed such lesions
(Fig. 4B).
Histological staining and scoring of elastin in aorta media
demonstrated a variation in the degree of elastin degradation in allApoE/ and ApoE/Trif/ mice infused with AngII compared to
saline-infused control aortas when stained with Verhoeff's van
Gieson (Supplementary ﬁgure 1). There were no differences in
elastin degradation between ApoE/ and ApoE/Trif/ mice
infused with AngII.
No difference in total serum cholesterol between AngII-infused
ApoE/and ApoE/Trif/ and saline-infused ApoE/ mice was
detected (Supplementary table II).3.3. Mice deﬁcient in TRIF display an anti-inﬂammatory proﬁle
through regulation of the cellular content
To further assess the outcome of TRIF deﬁciency on the in-
ﬂammatory response present during aneurysm formation, several
genes involved in the process were examined in the aortas from all
AngII-infused and saline-infused mice. Compared with saline-
infused mice, mRNA expression in the cellular contents showed
an increase in the leukocyte marker CD11b and the macrophage
marker CD68 in both groups of AngII-infused mice. However, the
expression of CD11b and CD68 were signiﬁcantly lower by 41%
(P < 0.05) and 40% (P < 0.05), respectively, in the aortas of ApoE/
Trif/mice compared to ApoE/mice infused with AngII (Fig. 5A
and B). The T lymphocyte marker CD3e showed a tendency of a
reduction (67%) in gene expression e to levels equal to saline-
infused control aortas e in ApoE/Trif/ mice compared with
aortas from ApoE/ AngII-infused mice (P ¼ 0.14; Fig. 5C). Gene
expression analysis of chemokine (CeC motif) ligand 2 (CCL2) and
CCL5 showed no signiﬁcant difference in gene expression between
Fig. 5. Gene expression of CD11b (A), CD68 (B), CD3e (C), TNF-a (D), adiponectin (E), MMP-12 (F), SM22a (G), collagen Ia1 (H), lysyl oxidase (LOX) (I), TLR3 (J), TLR4, (K) and Trif (L) in
saline-infused ApoE/mice and AngII-infused ApoE/ and ApoE/Trif/mice. *P < 0.05, **P < 0.01. “B” Outlier greater than 1.5 times the interquartile range. “C” Outlier greater
than 3 times the interquartile range.
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(Supplementary Fig. 2AeB). Inﬁltration of CD68 positive macro-
phages and CD3 positive T lymphocytes was further validated with
immunohistochemical staining where we found a higher inﬁltra-
tion of predominantly macrophages in AngII-infused ApoE/ mice
as compared to ApoE/Trif/ mice. Inﬁltration of macrophages
was mainly localized to the adventitia of the AngII-infused ApoE/mice while absent in AngII-infused ApoE/Trif/ mice
(Supplementary Fig. 3AeC). The expression of T lymphocytes was
found in both saline-infused and AngII-infused mouse aortas. In
ApoE/Trif/ mice infused with AngII, T lymphocytes were
localized to the media while in ApoE/ mice the expression was
found both in media and adventitia (Supplementary Fig. 3DeF).
Histological staining and semi-quantiﬁcation of CD68 positive cells
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(P < 0.01 and P < 0.05) in aortas of AngII-infused ApoE/ mice as
compared with ApoE/Trif/ mice infused with AngII
(Supplementary Fig. 3 GeH).
We further observed increased mRNA expression of the pro-
inﬂammatory marker TNF-a in AngII-infused ApoE/ mice. The
levels of TNF-a were 130% higher compared to ApoE/Trif/ mice
(P < 0.05; Fig. 5D). We also examined the expression of the anti-
inﬂammatory adipokine, adiponectin, and found a signiﬁcant
down regulation by 33% (P < 0.01) in the aortas from ApoE/ mice
infused with AngII as compared with ApoE/Trif/ mice, which
were similar to the saline-infused control aortas (Fig. 5E). We also
performed analysis of the anti-inﬂammatory factors TGF-b and IL-
10. TGF-b was expressed low in control aortas and signiﬁcantly
higher in AngII-infused ApoE/ mice and ApoE/Trif/ mice.
However, TGF-b was signiﬁcantly higher (P < 0.05; Supplementary
ﬁgure 2C) in aortas from AngII-infused ApoE/ mice compared to
aortas from ApoE/Trif/ mice, which resembled an expression
more towards the control. A difference in gene expression of IL-10
was not found between AngII-infused ApoE/ mice and ApoE/
Trif/ mice (Supplementary ﬁgure 2D). Another gene of interest
was IFN-b. Gene expression analysis demonstrated no differences
between saline-infused ApoE/ mice or AngII-infused ApoE/
mice and ApoE/Trif/ mice.
To determine the contribution of TRIF deﬁciency on matrix-
degrading proteases, gene expression analysis were performed on
relevant matrix degrading proteases in AAA formation
(Supplementary table I). Interestingly macrophage elastase MMP-
12 in the aortas from ApoE/Trif/ versus ApoE/ mice infused
with AngII was the only protease that showed a signiﬁcant reduced
expression by 72% (P < 0.01, Fig. 5F).
In ApoE/ mice infused with AngII a 38% (P ¼ 0.07) decreased
expression of the SMC marker SM22a was observed compared to
aortas from ApoE/Trif/ mice (Fig. 5G). Further, as compared
with ApoE/Trif/ mice, aortas from ApoE/ mice infused with
AngII exhibited a signiﬁcant increase in the synthesis of pro-
collagen Ia1 by 74% (P < 0.05) as well as lysyl oxidase (LOX) by
37% (P < 0.05), a key enzyme involved in post translational modi-
ﬁcation and maturation of collagens (Fig. 5HeI).
TRIF mediates signaling from TLR3 and TLR4, therefore gene
expression analysis was performed on these receptors. In the aortas
from ApoE/mice infused with AngII, the mRNA levels of TLR3 and
TLR4 were increased by 22% (P ¼ 0.14) and 23% (P < 0.05),
respectively, compared to ApoE/Trif/ mice (Fig. 5JeK). Gene
expressionwas also performed on Trif in order to assess the absence
of the gene in ApoE/Trif/ mice. ApoE/ infused with AngII
expressed the Trif gene to a similar extent as saline-infused control
mice. Mice deﬁcient in TRIF completely lacked Trif gene expression
(Fig. 5L).
4. Discussion
TLRs play a key role as initiators of both the innate and adaptive
immune systems and are important in many inﬂammatory dis-
eases. Here we demonstrate that genetic deﬁciency of TRIF in mice
with an ApoE/ background has an anti-inﬂammatory effect and
inhibits AngII-induced AAA formation. TRIF deﬁciency was associ-
ated with a more stable aorta together with reduced macrophage
and leukocyte content and markedly decreased expression of the
TNF-a cytokine and the MMP-12 protease.
MyD88 is thought to transduce signaling of all TLRs (except
TLR3), and it is a well-described adaptor protein in cardiovascular
research that has been shown to be important in the development
of cardiovascular disease [15]. It has previously been shown that
atherosclerosis-prone hypercholesterolemic ApoE/ mice with agenetic deﬁciency of either TLR4 or MyD88 had reduced aortic
atherosclerosis [8]. These mice had reduced lipid and macrophage
accumulation and markedly decreased expression of the proin-
ﬂammatory cytokine monocyte chemoattractant protein 1 (MCP-
1). In ApoE/MyD88/ double knockout mice, decreased levels of
the proinﬂammatory enzyme cyclooxygenase-2 (COX-2) and cyto-
kine IL-12p40 were observed compared to ApoE/TLR4/ double
knockout mice. This indicates an important role for TLR4 and
MyD88 signaling in atherosclerosis-prone hypercholesterolemic
mouse models [16]. A recent study performed by Owens and co-
workers reported that whole-body deﬁciency of MyD88 had a
profound effect on the reduction of AngII-induced AAA and
atherosclerosis. Deﬁciency of MyD88 in bone marrow-derived cells
also resulted in reduced AAA and atherosclerosis implying that the
effects of MyD88 on AAA and atherosclerosis are mediated by he-
matopoietic cells. Whole-body deﬁciency of TLR4 had a similar
ability to reduce AngII-induced vascular pathologies, although
bone marrow-deletion of TLR4 clearly demonstrated that these
effects were unrelated to MyD88-mediated signaling in hemato-
poietic cells [8].
In the past years, attention has been brought to TRIF, which is
also a cytoplasmic adaptor protein and is important for trans-
duction of TLR3 and TLR4 signaling. TRIF and its association to TLR3
and TLR4 have been studied in atherosclerosis [17]. Recently
Lundberg et al. demonstrated that hematopoietic deﬁciency of TRIF
in LDLR/ mice led to a 40% reduction in lesion size compared to
control mice. These effects were accompanied by reduced inﬁltra-
tion of macrophages and T lymphocytes together with lower
expression of pro-inﬂammatory TNF-a, IFN-g, and IL-6 as well as
CCL2, CCL5, and chemokine (C-X-C motif) ligand 10 (CXCL10) all of
which are important for the recruitment of macrophages and T
lymphocytes in atherosclerosis [17]. However, the role of TRIF in
AAA formation is currently unknown.
Although many risk factors are known for AAA, including
smoking, atherosclerosis, inﬂammation, male gender, and age, the
etiology of human AAA is still not well understood. To gain an
insight into the mechanism of AAA, several animal models have
been developed [18]. One of the morewidely used animal models is
infusion of AngII that results in many features similar to the human
disease, including luminal dilatation, leukocyte inﬁltration, extra-
cellular matrix deformation, and thrombus formation [19]. In the
present study we demonstrated that ApoE/ mice infused with
AngII displayed a large aneurysm with a disorganized vessel
morphology associated with pronounced adventitial remodeling e
including thrombus formation in some of the vessels e as previ-
ously described in the literature [20]. We also demonstrated that
deﬁciency in TRIF was protective against AngII-induced aneurysm
formation. These ApoE/Trif/ mice exhibited a more organized
vessel wall, lacked thrombotic material, and had an aortic mass
similar to the saline-infused control aortas compared to ApoE/
mice infused with AngII. However these mice still exhibited elastin
degradation similar to ApoE/mice infused with AngII. Expression
of the SMC markers SM22a indicated a tendency towards a signif-
icant increase in ApoE/Trif/ mice compared with ApoE/ mice
infused with AngII, suggesting that TRIF might play an important
role in reducing SMC apoptosis or increasing proliferation. SMCs
are one of the major producers of matrix collagen. In aneurysm,
increased collagen synthesis occurs as a response to matrix
degradation and expansion of the vessel wall in the initial/early
phase of aneurysm disease. We demonstrated that ApoE/ mice
infused with AngII had a high synthesis of pro-collagen Ia1 as well
as LOX, a key enzyme involved in post translational modiﬁcation
and maturation of collagens, as a response to aneurysmal forma-
tion. ApoE/Trif/ mice however, lacking aneurysm formation,
displayed synthesis of pro-collagen I to similar expression as saline-
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One of the early key events in the progression of AngII-induced
AAA is inﬁltration of macrophages predominantly localized to the
adventitia whereas in later stages inﬁltration of other leukocytes
such as T and B lymphocytes can be detected [21,22]. We found
reduced levels of leukocytes, including macrophages and T lym-
phocytes, in the aortic wall in ApoE/Trif/ mice together with
decreased levels of the pro-inﬂammatory cytokine TNF-a e
important for the initiation of inﬂammation e as well as the
macrophage protease MMP-12. These mice also show increased
levels of adiponectin, a protein known to exert anti-inﬂammatory
effects in the aorta and to attenuate aneurysm formation [23,24].
The effects observed within the vessel wall of ApoE/Trif/ mice
might be both haematopoietic effects and inﬂuence of the vascular
cells. These results suggest that TRIF signaling increases aneurysm
formation by promoting the inﬁltration of immune cells such as
macrophages and T lymphocytes into the aortic wall. Of all AngII-
infused ApoE/ mice, 55% displayed an aneurysm formation ac-
cording to the deﬁnition provided above. However, all AngII-
infused ApoE/ mice had similar increases in inﬂammatory re-
sponses in their aortas. Of all ApoE/Trif/ mice infused with
AngII only one mouse developed an aneurysm. This aorta displayed
an inﬂammatory response to the same extent as ApoE/ mice
infused with AngII which can be observed as an outlier in several
ﬁgures. This outlier affected the outcome of several genes, among
these the macrophage protease cathepsin K, CCL2 and SM22a. If
removing this outlier these genes are signiﬁcantly different be-
tween ApoE/Trif/ mice and ApoE/ mice infused with AngII.
TLRs play a key role in the innate immune response and are
involved in many inﬂammatory diseases, including atherosclerosis
[10]. During aneurysmal progression, fragments from the extra-
cellular matrix such as ﬁbronectin and hyaluronan, among others,
are released due to tissue damage and matrix remodeling. These
components are known to trigger the TLRs and thereby lead to NF-
kB activation. In the present study, we identiﬁed increased TLR3
and TLR4 expression in human AAA in association with macro-
phages and T lymphocytes and to some extent with endothelial
cells and SMCs. Similar to mice lacking TRIF, Lundberg et al. also
demonstrated that TLR3 deﬁciency in hematopoietic cells in LDLR/
 mice resulted in reduced atherosclerotic plaques with markedly
decreased levels of macrophages and T lymphocytes suggesting
that TRIF mediates its proatherogenic role downstream of TLR3
[17]. In line with these data, Zimmer et al. demonstrated that TLR3
enhanced atherosclerotic plaque formation in ApoE/ mice [25].
We further investigated the presence of TLR3 and TLR4 in aortas
from experimentally induced AAA in mice and found an up regu-
lation of TLR4 in the ApoE/ mice infused with AngII. However,
deﬁciency of the adaptor protein TRIF reduced the expression of
TLR4, and this might be explained by impaired recruitment of in-
ﬂammatory cells to the aortic tissue. These data suggest that
signaling trough TRIF promotes aneurysmal progression and for-
mation in ApoE/ mice infused with AngII and that reduced
aneurysmal formation in ApoE/ mice deﬁcient in TRIF is associ-
ated with reduced vascular inﬂammation.
5. Conclusion
TRIF is an essential adaptor protein in the TLR signaling pathway
that triggers the inﬂammatory response in the aortic wall and is
important in the initiation and progression of AAA. In this study we
show that mice deﬁcient in TRIF have reduced inﬂammation;
reduced levels of macrophages, T lymphocytes, and pro-
inﬂammatory TNF-a and proteases; and a more organized aortic
morphology. Taken together, our results suggest that TRIF affects
the inﬂammatory response of AngII-induced AAA and that blockageof the TRIF pathway reduces vascular inﬂammation and protects
against AAA formation.
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